Continuous subcutaneous insulin infusion.
D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D007332:Insulin Infusion Systems / Q000009:adverse effects / Q000592:standards*; D018579:Patient Selection; D011785:Quality Assurance, Health Care; D012449:Safety; D014481:United States